Hiroyoshi Kunimoto1, Hideaki Nakajima1, Ross Levine2,3, Alan Shih2,3 (1.Hematol., Yokohama City Univ., Yokohama, Japan, 2.HOPP, Memorial Sloan Kettering Cancer Center, New York, USA, 3.Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, USA)
Session information
Oral Session
Oral Session 1-11D MDS: Basic (2)
Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.11 (Osaka International Convention Center, 10F 1004-5)
Chair: Hironori Harada (Tokyo University of Pharmacy and Life Sciendes, Japan)
[OS1-11D-2] Efficacy of a newly oral DNA methyltransferase inhibitor (OR21) in MDS and AML cell line
Hiroshi Ureshino, Yuki Kurahashi, Tatsuro Watanabe, Shinya Kimura (Drug discovery and biochemical sciences, Saga Uni., Saga, Japan)
Junji Tokushige, Yosuke Masamoto, Mineo Kurokawa (Dept. Hem/Onco., Tokyo Univ., Tokyo, Japan)
Jun-Ichiro Kida1, Takayuki Tsujioka1, Shin-Ichiro Suemori1, Shuichiro Okamoto1, Kanae Sakakibara1, Takahiro Yamauchi2, Akira Kitanaka1, Yumi Tohyama3, Kaoru Tohyama1 (1.Department of Laboratory Medicine, Kawasaki Medical School, Okayama, Japan, 2.Department of Hematology and Oncology, University of Fukui, Fukui, Japan, 3.Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Hyogo, Japan)
Seiichiro Katagiri1, Kenko Azuma2, Yuu Saitoh1, Seiichiro Yoshizawa1, Daigo Akahane1, Hiroaki Fujimoto1, Yoshikazu Ito1, Tomohiro Umezu1,2, Junko H. Ohyashiki2, Kazuma Ohyashiki1 (1.Department of Hematology, Tokyo Medical University, Tokyo, Japan, 2.Institute of Medical Science, Tokyo Medical University, Tokyo, Japan)
June Takeda1, Lee-Yung Shih2, Kenichi Chiba3, Yuichi Shiraishi3, Yusuke Shiozawa4, Hideki Makishima1, Tetsuichi Yoshizato1, Yasunobu Nagata5, Akira Hangaishi6, Ken Ishiyama7, Hisashi Tsurumi8, Yasushi Miyazaki9, Nobuhiro Hiramoto10, Takayuki Ishikawa10, Akifumi Takaori-Kondo11, Keisuke Kataoka1, Masashi Sanada12, Hiroko Tanaka3, Kensuke Usuki6, Shuichi Miyawaki13, Satoru Miyano3, Arnold Ganser14, Michael Heuser14, Felicitas Thol14, Ayana Kon1, Yasuhito Nannya1, Kenichi Yoshida1, Seishi Ogawa1,15 (1.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.Division of Haematology-Oncology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 3.Human Genome Centre, The University of Tokyo, 4.Department of Pediatrics, The University of Tokyo, Japan, 5.Department of Haematology and Oncology, Cleveland Clinic, Cleveland, OH, US, 6.Department of Haematology, NTT Medical Centre Tokyo, Tokyo, 7.Department of Haematology, Kanazawa University, Kanazawa, Japan, 8.Department of Hematology, Gifu University, Gifu, Japan, 9.Department of Hematology, Nagasaki University, Nagasaki, Japan, 10.Department of Hematology, Kobe City Medical Center General Hospital, 11.Department of Haematology/ Oncology, Kyoto University, Kyoto, Japan, 12.Department of Advanced Diagnosis, Nagoya Medical Centre, Nagoya, Japan, 13.Division of Haematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan, 14.Department of Haematology, Hannover Medical School, Hannover, Germany, 15.Canter for Hematology and Regenerative Medicine, Karolinska Institute, Sweden)